Morbidity and Mortality in Patients Undergoing Coronary Artery Bypass Surgery With and Without Acute Myocardial Infarction

Authors

  • Oscar Talledo Quaglino Servicio de Cirugía de Tórax, Cardiovascular e Intervención Endovascular. Clínica AngloAmericana. Lima, Perú.
  • Adriana Gutierrez-Yllu Servicio de Cirugía de Tórax, Cardiovascular e Intervención Endovascular. Clínica AngloAmericana. Lima, Perú. https://orcid.org/0000-0002-3084-1594

DOI:

https://doi.org/10.20453/rmh.v36i2.5338

Keywords:

Coronary Artery Bypass, Myocardial Infarction, Coronary Artery Disease

Abstract

Objective: To compare morbidity and mortality in patients undergoing coronary artery bypass graft (CABG) surgery with acute myocardial infarction (AMI) and electively (non-AMI). Methods: Retrospective cohort study. Medical records of 237 patients who underwent CABG for three-vessel and/or left main disease were reviewed. 63 patients had surgery during AMI, and 174 had elective surgery. Morbidity and mortality were compared during the hospital stay or within 30 postoperative days. Results: Clinical characteristics were similar in both groups. Operative mortality was higher in the AMI group (7.94% vs. 1.15%, p = 0.006). Common postoperative complications in the AMI group were: stroke (7.94% vs. 0.57%, p = 0.001), reoperation for bleeding (6.35% vs. 1.15%, p = 0.024), and acute kidney injury (15.2% vs. 3.5%, p = 0.009). Conclusions: CABG during AMI in patients with three-vessel/left main disease was associated with more frequent neurological complications, reoperations for bleeding, transient acute kidney injury, and higher mortality compared to elective surgery.

Downloads

Download data is not yet available.

Author Biographies

Oscar Talledo Quaglino, Servicio de Cirugía de Tórax, Cardiovascular e Intervención Endovascular. Clínica AngloAmericana. Lima, Perú.

       

Adriana Gutierrez-Yllu, Servicio de Cirugía de Tórax, Cardiovascular e Intervención Endovascular. Clínica AngloAmericana. Lima, Perú.

       

References

Organización Mundial de la Salud (OMS). Las 10 principales causas de defunción [Internet]. 2020 [citado 1 de septiembre de 2023]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/the-top-10-causes-of-death

Reyes, M. Vlásica, J. Registro Nacional de Infarto al Miocardio III (2014). Rev Per Card. 2018; XLIV(2):46-66. Disponible en: https://sopecard.org/revista-sp/2018/Revista-2-2018.pdf

Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, et al. Decline in Cardiovascular Mortality: Possible Causes and Implications. Circ Res. 2017;120(2):366-80. doi: 10.1161/CIRCRESAHA.116.309115

Murphy ML., Hultgreen HN, Detre K, et al: Treatment of Chronic stable angina: A preliminary report of survival data of the randomized Veterans Administration Cooperative Study. N Engl J Med. 1977; 297:621.

The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group, 1984: Eleven-year survival in the Veterans Administration Randomized Trial of Coronary Bypass Surgery for stable angina. N Engl J Med. 1984; 311:1333-1339. doi: 10.1056/NEJM198411223112102.

Yusuf S, Zucker D, Passamani E, Peduzzi P, Takaro T, Fisher LD, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. The Lancet. 1994;344(8922):563-70.

Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, Killip T, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990 Nov;82(5):1629-46. doi: 10.1161/01.cir.82.5.1629.

Thuijs DJFM, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomized controlled SYNTAX trial. The Lancet. 2019;394(10206):1325-34. doi: http://dx.doi.org/10.1016/ S0140-6736(19)31997-X.

Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, et al. Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease. N Engl J Med. 2015;372(13):1204-12. doi: 10.1056/NEJMoa1415447.

Fearon WF, Zimmermann FM, De Bruyne B, Piroth Z, Van Straten AHM, Szekely L, et al. Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery. N Engl J Med. 2022;386(2):128-37. doi: 10.1056/NEJMoa2112299.

Warren J, Mehran R, Baber U, Xu K, Giacoppo D, Gersh BJ, et al. Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials. Am Heart J. 2016;171(1):40-7. doi: 0.1016/j.ahj.2015.07.001.

Hansson EC, Jidéus L, Åberg B, Bjursten H, Dreifaldt M, Holmgren A, et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J. 2016;37(2):189-97. doi: 10.1093/eurheartj/ehv381.

Mao Z, Zhong X, Yin J, Zhao Z, Hu X, Hackett ML. Predictors associated with stroke after coronary artery bypass grafting: A systematic review. J Neurol Sci. 2015;357(1-2):1-7. doi: http://dx.doi.org/10.1016/j.jns.2015.07.006.

Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med. 2009;360(10):961-72. doi: 10.1056/NEJMoa0804626.

Åström A, Söderström L, Mooe T. Risk of Ischemic Stroke After Acute Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery. Sci Rep. 2020;10(1):3831. doi: https://doi.org/10.1038/s41598-020-60854-1.

Kandimalla J, Hussain Z, Piriyawat P, Rodriguez G, Maud A, Khatri R, et al. Stroke Rates Following Surgical Versus Percutaneous Revascularization for Ischemic Heart Disease. Curr Cardiol Rep. 2021;23(5):45. doi: 10.1007/s11886-021-01471-w.

Braxton JH, Hammond GL, Letsou GV, Franco KL, Kopf GS, Elefteriades JA, et al. Optimal Timing of Coronary Artery Bypass Graft Surgery After Acute Myocardial Infarction. Circulation. 1995;92(9):66-8. doi: https://doi.org/10.1161/01.CIR.92.9.66.

Bernard C, Morgant MC, Jazayeri A, Perrin T, Malapert G, Jazayeri S, et al. Optimal Timing of Coronary Artery Bypass Grafting in Haemodynamically Stable Patients after Myocardial Infarction. Biomedicines. 2023;11(3):979. doi: https://doi.org/10.3390/ biomedicines11030979.

ElBardissi AW, Aranki SF, Sheng S, O’Brien SM, Greenberg CC, Gammie JS. Trends in isolated coronary artery bypass grafting: An analysis of the Society of Thoracic Surgeons adult cardiac surgery database. J Thorac Cardiovasc Surg. 2012;143(2):273-81. doi: 10.1016/j.jtcvs.2011.10.029.

Schwann TA, Habib RH, Wallace A, Shahian DM, O’Brien S, Jacobs JP, et al. Operative Outcomes of Multiple-Arterial Versus Single-Arterial Coronary Bypass Grafting. Ann Thorac Surg. 2018;105(4):1109-19. doi: https://doi.org/10.1016/j.athoracsur.2017.10.058.

Rojas F. Morbilidad y mortalidad en revascularización miocárdica Hospital Nacional Edgardo Rebagliati Martins. Estudio de 168 casos. Rev Peruana Card. 2003; 29(3):163-171.

Reyes M, Ruiz E. Registro Nacional de Infarto de Miocardio Agudo II. RENIMA II. Rev Peruana Card. 2013;39(1):60-71.

Reyes M, Heredia J, Campodónico S, Drago J, Alvarado O. Registro nacional de infarto miocárdico agudo (RENIMA). Rev Peruana Card. 2008; 34(2):84-98.

Published

2025-06-30

How to Cite

1.
Talledo Quaglino O, Gutierrez-Yllu A. Morbidity and Mortality in Patients Undergoing Coronary Artery Bypass Surgery With and Without Acute Myocardial Infarction. Rev Méd Hered [Internet]. 2025 Jun. 30 [cited 2025 Jul. 17];36(2):123-9. Available from: http://44.198.254.164/index.php/RMH/article/view/5338